Selvita SA (PL:SLV)

:SLV

SLV

Selvita SA

RESEARCH TOOLSreports

Selvita SA (SLV) Price & Analysis

3 Followers

SLV Stock Chart & Stats

zł46.50

Market closed

zł46.50

Day’s Range― - ―

52-Week Rangezł26.50 - zł49.40

Previous CloseN/A

VolumeN/A

Average Volume (3M)40.05K

Market Cap

zł644.28M

Enterprise Valuezł817.59M

Total Cash (Recent Filing)zł17.02M

Total Debt (Recent Filing)zł190.33M

Price to Earnings (P/E)―

Beta0.91

Next Earnings

May 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding18,355,474

10 Day Avg. Volume21,446

30 Day Avg. Volume40,050

Financial Highlights & Ratios

PEG Ratio1.37

Price to Book (P/B)2.82

Price to Sales (P/S)2.66

P/FCF Ratio20.03

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)1.01

Revenue Forecast (FY)zł412.68M

SLV FAQ

What was Selvita SA’s price range in the past 12 months?

Selvita SA lowest stock price was zł26.50 and its highest was zł49.40 in the past 12 months.

What is Selvita SA’s market cap?

Selvita SA’s market cap is zł644.28M.

When is Selvita SA’s upcoming earnings report date?

Selvita SA’s upcoming earnings report date is May 27, 2026 which is in 55 days.

How were Selvita SA’s earnings last quarter?

Currently, no data Available

Is Selvita SA overvalued?

According to Wall Street analysts Selvita SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Selvita SA pay dividends?

Selvita SA does not currently pay dividends.

What is Selvita SA’s EPS estimate?

Selvita SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Selvita SA have?

Selvita SA has 18,355,474 shares outstanding.

What happened to Selvita SA’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Selvita SA?

Currently, no hedge funds are holding shares in PL:SLV

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Selvita SA

Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Krakow, Poland.